Andlauer Healthcare Group Inc.
AND.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.26% | 0.13% | 0.72% | -1.89% | 1.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.26% | 0.13% | 0.72% | -1.89% | 1.75% |
| Cost of Revenue | -2.55% | -1.64% | 0.20% | -1.91% | 3.07% |
| Gross Profit | -4.60% | 3.71% | 1.79% | -1.85% | -0.66% |
| SG&A Expenses | -3.33% | 3.10% | 10.21% | -1.93% | -7.42% |
| Depreciation & Amortization | -1.13% | -0.96% | 2.74% | 9.78% | 5.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.44% | -1.10% | 1.46% | -0.52% | 2.25% |
| Operating Income | -7.33% | 7.77% | -3.65% | -10.04% | -0.66% |
| Income Before Tax | -9.02% | 4.64% | -2.26% | -8.68% | -4.00% |
| Income Tax Expenses | -11.10% | 5.17% | -3.67% | -6.57% | 3.38% |
| Earnings from Continuing Operations | -8.22% | 4.44% | -1.73% | -9.42% | -6.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.22% | 4.44% | -1.73% | -9.42% | -6.59% |
| EBIT | -7.33% | 7.77% | -3.65% | -10.04% | -0.66% |
| EBITDA | 60.56% | 2.62% | -30.55% | -32.55% | -11.71% |
| EPS Basic | -3.54% | 11.03% | 0.21% | -8.23% | -5.16% |
| Normalized Basic EPS | -4.39% | 11.26% | -0.33% | -7.50% | -2.55% |
| EPS Diluted | -2.47% | 12.00% | 0.84% | -9.95% | -6.53% |
| Normalized Diluted EPS | -3.46% | 11.68% | -0.04% | -7.43% | -2.74% |
| Average Basic Shares Outstanding | -4.86% | -5.95% | -1.93% | -1.26% | -1.49% |
| Average Diluted Shares Outstanding | -5.78% | -6.28% | -2.22% | -1.36% | -1.28% |
| Dividend Per Share | 18.73% | 20.27% | 22.65% | 25.55% | 28.29% |
| Payout Ratio | 0.23% | 0.08% | 0.18% | 0.36% | 0.36% |
